MONASH University has
issued a robust response to
reported claims by PSA
President Warwick Plunkett
about Monash and other large
universities being to blame for
excess pharmacy graduates.
Monash Dean of Pharmacy,
Prof William Charman, said
that in fact the current Monash
intake is the same as in 2004/5,
as part of a deliberate strategy
to provide the “best learning
environment” - along with $50m
in new facilities.
He said Monash is concerned
about the proliferation of
pharmacy schools in Australia
and a “lack of clarity, future
planning and governance”,
adding that the current number
of schools “is not sustainable”.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.